The surprising finding is that, in some animals and plants, the transport of a silencing signal between cells allows the same gene to be specifically silenced in cells that had not encountered the primary dsRNA. This process has been best characterized in plants and Caenorhabditis elegans 1 . In plants, silencing RNAs move from cell to cell through plasmodesmata and over long distances through the phloem vascular tissue 2 . When a leaf is infected with a plant virus, mobile signals transmitted to other leaves confer them resistance to the virus and thus prevent the spread of the infection. Although viral-induced small interferin g RNAs (siRNAs) and transgenes were known for many years to move through the plant, the movement of endogenous small RNAs (sRNAs) has only recently been demonstrated [3] [4] [5] . The mobility of endogenous sRNAs, including microRNAs (miRNAs), generates morphogenic signalling gradients that guide the patterning of leaves and roots 3 . Mobile sRNAs promote epigenetic modifications in the genome of recipient cells 5 . Furthermore, when the recipient cells are seed or pollen, mobile sRNAs induce transgenerational epigenetic changes to enhance adaptation of progeny to future stresses 6 
. In C. elegans, silencing triggered by injected, ingested or locally expressed dsRNA can spread throughout the organism to silence the targeted gene in all non-neuronal cells, including the germ line, and thus transmit silencing to the next generation [7] [8] [9] [10] . The exchange of genetic information between mammalian cells is a more recent concept. sRNAs have been detected in blood and other body fluids such as urine, saliva and milk. Most circulating sRNAs are contained within lipids or lipoprotein complexes, apoptotic bodies or exosomes, which efficiently protect them from degradation by serum ribonucleases. Recent reports indicate that RNAs, contained within exosomes, are transferred to recipient cells and modulate the function of the cell [11] [12] [13] [14] . In this Opinion article, we discuss recent studies that describe the trafficking of genetic material in mammals, focusing on extracellular vesicles and the diverse structures that cells utilize for communication. We also discuss the potential of cellular synapses and other connective structures to act as specialized devices for mediating intercellular transfer of genetic material and explore the potential biological relevance of this mode of communication.
Genetic transfer via extracellular vesicles
Until recently, firm evidence for inter cellular transfer of RNA in mammals remained elusive. The discovery that extracellular vesicles contain genetic material that can be exchanged between cells, either directly or via body fluids, supports the notion that this form of exchange of genetic information is biologically significant in mammals.
Box 1 | Mechanisms of systemic RNA silencing in plants RNA interference (RNAi) can move from cell to cell through plasmodesmata and spread throughout the organism via the phloem 1, 2 . Plants can transport RNA from older tissues to the root or shoot meristems along the direction of phloem flow. Long-distance spreading of RNA (which occurs via small RNAs (sRNAs)) has been demonstrated by grafting rootstocks that express an inverted repeat (IR) that targets green fluorescent protein (GFP) mRNA (see the figure, part  a) . The recipient grafted tissues (shown in dark green) overexpress GFP. Emerging new growth is uniformly silenced (shown in pale green), suggesting the propagation of a GFP-specific silencing signal. The silencing signal might be transported as single-stranded RNA (ssRNA) bound to phloem small RNA-binding protein 1 (PSRP1) or possibly inside extracellular vesicles (as double-stranded RNA (dsRNA)) (see the figure, part a) .
Plasmodesmata are dynamic intercellular channels that establish symplasmic continuity between neighbouring cells (see the figure, part b) . dsRNA, derived from transgenic or endogenous loci, is processed by Dicer-like enzymes (DCLs). DCL3 and DCL4 produce primary 24-nucleotide (nt) or 21-nt small interfering RNAs (siRNAs), respectively. The 24-nt siRNA can be directed to the transcriptional gene silencing (TGS) pathway by Argonaute 4 (AGO4), whereas the 21-nt siRNA binds to AGO1, which results in the cleavage of complementary mRNAs via the post-transcriptional gene silencing (PTGS) pathway (local silencing). Both 21-nt and 24-nt duplexes can move from cell to cell through plasmodesmata (short-range spreading). It is unclear whether RNAs move through plasmodesmata freely by diffusion or through a regulated mechanism involving protein interactions. Silencing signals can travel through 10 to 15 contacting cells without amplification, but RNA-dependent RNA polymerases (RDRs) can direct the synthesis of secondary siRNAs to amplify and spread the silencing information (long-range spreading). Both siRNA types can initiate signal amplification in recipient tissues via the actions of RNA polymerase IV (Pol IV) and RDRs. Exosomes, which have a diameter of 30-100 nm, are intraluminal vesicles (ILVs), which form inside late endosomes (also known as multivesicular bodies (MVBs)) 16 . MVBs release exosomes by fusing with the plasma membrane. The endosomal origin of exosomes is reflected in their molecular composition, which includes apoptosis-linked gene 2-interacting protein X (ALIX; also known as PDCD6IP), CD63 and tumour susceptibility gene 101 (TSG101). All exosomes contain proteins that are involved in membrane transport and fusion (such as RAB GTPases, annexins and others). Cytoskeletal proteins, adhesion molecules and tetra spanin family proteins (such as tetraspanins CD81, CD82 and CD63) are also abundant. Furthermore, exosome membranes have a specific lipid composition, being enriched in lipids such as cholesterol, ceramide and sphingolipids. Ceramide is involved in the budding of ILVs into MVBs. Consistently, blockade of neutral sphingomyelinase 2 (nSMase2), which is an enzyme involved in ceramide synthesis, inhibits exosome production 17 . In mammals, the ESCRT complex (endosomal sorting complex required for transport) might not control MVB formation but could function to ensure proper ILV composition 18 .
Several RAB proteins (such as RAB11, RAB27 and RAB35) contribute to exosome secretion 19 . The final step of exosome secretion, which is the fusion of MVBs with the plasma membrane, is likely to involve a complex of SNARE proteins 19 . Exosomes are released constitutively, although their sec retion can be increased in response to cell activation or stress.
Ectosomes, which are also termed shedding vesicles, are usually larger than exosomes (with a diameter of 100 nm to 1 μm) and are produced by direct plasma membrane blebbing 20 . They are thought to arise from regions of the membrane enriched in lipid rafts, and they expose phosphatidylserine in the outer leaflet of their membrane. Except for tumour cells, which constitutively shed large numbers of ectosomes, the rate of release is low and can be increased by cell activation or apoptosis.
Apoptotic bodies are larger than ectosomes or exosomes (>1 μm in diameter) and are released as blebs of apoptotic cells. They are characterized by phosphatidyl serine externalizatio n and contain fragmented DNA.
Consequences of genetic transfer
Extracellular vesicles have emerged as potent vehicles for cell-to-cell communication since the discovery that they contain functional mRNA, miRNA and DNA molecules that can be taken up by target (acceptor) cells [12] [13] [14] 21, 22 .
Early studies showed that secreted vesicles derived from embryonic stem cells or tumour cells contain mRNA 21 , and that these transcripts can be delivered to target cells where they are translated into functional proteins 11 . Subsequently, extracellular vesicles were shown to also contain sRNA species 12 . Even DNA can be transferred, for example to fibroblasts and endothelial cells, through phagocytosis of tumour apoptotic bodies 22 . In addition, viral miRNAs 23, 24 and retrotransposon RNA transcripts from human endogenous retro viruses 25 can be detected in extracellular vesicles and can be transferred to acceptor cells 24 . The genetic content of extracellular vesicles is not simply a straightforward reflection of the genetic content of the cell of origin; specific populations of RNAs are selectively packaged into exosomes 11, 13, 14 , indicating the existence of an as yet unknown mechanism controlling the sorting of specific RNAs. It is likely that the ESCRT protein complex is a mediator of this process, as ESCRTII can directly bind RNA 26 and the blockade of MVB formation by ESCRT depletion impairs miRNA silencing 27, 28 . Another possibility is that the nucleic acid sequences themselves directly control their trafficking to extracellular vesicles.
Once they are released, extracellular vesicles can either target a nearby cell or reach a distant cell by entering the bloodstream, but the mechanisms by which target cells take up and integrate RNA carried by extracellular vesicles are poorly understood. The functional consequences of this transfer depend on the origin and status of the donor and recipient cells. For example, extracellular vesicles derived from endothelial progenitors drive angiogenesis via the horizontal transfer of mRNAs to quiescent endothelial cells 29 . Apoptotic bodies can transfer miR-126 to endothelial cells; this miRNA silences the endogenous G protein signalling inhibitor RGS16 (regulator of G protein signalling 16), and this promotes an autoregulatory feedback loop in recipient cells that increases secretion of CXCL12, inducing endothelial repair and protecting against diet-induced athero sclerosis 30 . Furthermore, extracellular vesicles from patients with atherosclerosis are enriched in miR-150 and promote endothelial cell migration by downregulating the miR-150 target c-MYB 31 . miR-143 and miR-145 are enriched in extracellular vesicles produced by endothelial cells and can be transferred to smooth muscle cells 32 . This mechanism of cell-to-cell behavioural regulation is particularly important in cancer.
Tumour cells produce abundant extracellular vesicles, with the potential to influence the behaviour of surrounding healthy cells in order to facilitate tumour growth, metastasis or immune evasion. Tumour-cell-derived extracellular vesicles can induce angiogenesis by delivering RNA to endothelial cells 11, 33 and can also deliver DNA (including oncogenes such as c-Myc) or retrotransposon RNA transcripts from human endogenous retroviruses to normal cells 25 . In the immune system, exosomes from T cells or dendritic cells can fuse with the plasma membrane of target cells, releasing the cargo of functional miRNA s into their cytoplasm 13, 14 .
Vesicle-free circulating RNA miRNA can also circulate in body fluids in a vesicle-independent form [34] [35] [36] [37] . Argonaute 2 (AGO2), the key effector protein of miRNA-mediated silencing, forms circulating ribonucleoprotein complexes . Other associated RNA-binding proteins, such as nucleophosmin 1 (NPM1), can form complexes with miRNAs and protect them from degradation. Although the mechanism that regulates export of circulating ribonucleoprotein complexes is unknown, it seems to be an active energy-dependent process.
Several screens have identified the genes involved in dsRNA uptake and spreading in C. elegans. Cellular uptake of dsRNA involves SID-1 (systemic RNAi defective protein 1). SID-1, which is a multipass transmembrane protein expressed by all non-neuronal cells, allows long dsRNAs and their derivatives to move passively from cell to cell across the cell membrane 10 . The potential ability of SID-1 to transport endogenous dsRNA is supported by recent evidence showing that SID-1 imports synthetic miRNA precursors and long hairpin molecules 38 . Another gene involved in dsRNA transfer in C. elegans is rsd-3, a homologue of the mammalian protein epsin-related protein (epsinR; also known as CLINT1), which is involved in vesicle trafficking through its epsin amino-terminal homology (ENTH) domain 9 . In mammals, miRNAs can also be transported by high-density lipoproteins (HDLs) and be delivered to recipient cells to modulate their function 36 . Inhibition of nSMase2, which blocks the release of miRNA-loaded exosomes 13, 17, 39 , increases the amount of miRNAs exported to HDLs. Thus, nSMase2 and the ceramide pathway might regulate different but coordinated pathways of miRNA secretion. HDL-miRNA delivery to recipient cells is dependent on scavenger receptor class B type I (SRBI) 36 . Mammalian homologues of C. elegans SID proteins exist and could also participate in lipid-modified siRNA uptake 40 .
Cell-to-cell genetic transfer Although transfer of genetic material does not require cell-to-cell contact, it has been suggested that, as occurs in plants, sRNAs move between mammalian cells through highly organized cell-cell structures such as gap junctions, intercellular bridges or synapse s (FIGS 2,3 41 . Shuttling of miRNAs through gap junctions has been described between cardiac cells 42, 43 , bone-marrow stromal and tumour cells 44 and glioma cells 45 . Transfer of siRNAs and miRNAs is impaired by overexpressing a dominant-negative connexin 43 mutant 42 and by gap junction channel uncouplers [43] [44] [45] . In these studies, the passage of fluorescently tagged siRNA analogues or overexpressed miRNAs was observed. However, further studies are needed to confirm physiological transfer of RNAs. The molecular pathways regulating the movement of sRNAs through gap junctions are as yet unknown.
At the end of cytokinesis, daughter mammalian cells are transiently connected by an intercellular bridge. But in the germ line, these transient structures are transformed into stable intercellular bridges that interconnect hundreds of daughter cells in a syncytium. Intercellular bridges are essential for male fertility. They are composed of general cytokinesis molecules and additional germ cell-specific factors such as testis-expressed protein 14 (TEX14). TEX14 is required for the intercellular bridge stability in gametes of both sexes. RNA binding motif protein 44 (RBM44) is found at intercellular bridges and interacts with TEX14, and it may parti cipate in RNA transport. Intercellular bridges allow sharing of mRNA between post-meiotic haploid spermatids, keeping them phenotypically diploid 46 . Cytoplasmic granules loaded with RNA and RNA binding proteins (which in germ cells have been called chromatoid bodies (C-bodies) and are related to processing bodies (P-bodies)) can move between spermatids through the intercellular bridge 47 . Nonetheless, evidence supporting cell-to-cell movement of sRNA through gap junctions or intercellular bridges is scarce, and other mechanisms such as nanotubes 48 cannot be excluded.
Genetic exchange through synapses
Recent evidence indicates that specialized junctional structures such as synapses constitute efficient communication gateways. The intrinsic stability of these junctions promotes the exchange of vesicles and the During immune synapsis, the molecules involved in antigen recognition (such as T cell receptor (TCR) and peptide-loaded major histocompatibility complex (pMHC) molecules) move to a central cluster surrounded by a peripheral ring enriched in adhesion molecules (such as the integrin leukocyte function-associated antigen 1 (LFA1) and intercellular cell adhesion molecules (ICAMs)) and the actin cytoskeleton. The T lymphocyte orients its microtubule-organizing centre (MTOC) and secretory compartments (such as the Golgi apparatus and multivesicular bodies (MVBs)) towards the antigen presenting cell (APC). We propose that the immune synapse provides a more efficient path for the exchange of genetic material through the combination of different mechanisms, including the polarized secretion of microRNA (miRNA)-loaded exosomes, transendocytosis and membrane bridges. Pathogens, including bacteria and viruses, hijack biological synapses to spread from cell to cell.
formation of additional structures, providing an appropriate environment for the exchange of genetic material. Immune synapses are formed at the T cell-antigenpresenting cell (APC) interface during antigen recognition, and these synapses have a central role in T cell activation and in the polarized delivery of effector molecules such as cytokines and lytic granules 49 . The T cell receptor (TCR) and associated signalling protein complexes accumulate in a central cluster (central supramolecular activating complex (cSMAC)) surrounded by a peripheral ring of adhesion molecules (pSMAC). Signalling triggers massive reorganization of the actin and microtubule cytoskeletons, with the T cell microtubule-organizing centre (MTOC) moving towards the plasma membrane at the cSMAC 50 . Both the Golgi and MVBs localize at the synapse 13, 51 , where exocytosis and endocytosis occur 52 (FIG. 3) .
We propose that immune synapses facilitate the passage of genetic molecules between cells. The immune synapse promotes exchange of miRNA-loaded exosomes between a T lymphocyte and its cognate APC 13 . Transfer of plasma membrane-associate d proteins among interacting immune cells is well established 53 . Besides promoting the exchange of exosomes, immune synapses also might facilitate transendocytosis and the formation of nanotubes, gap junctions and membrane bridges between the two cell membranes that mediate direct exchange of proteins [54] [55] [56] [57] [58] (FIG. 3) . Whether regulatory RNA transfer between immune cells occurs through these structure s needs to be addressed.
In the neural system, intercellular communication is primarily mediated by the release of neurotransmitters from the axon of the afferent neuron into the synaptic cleft and the capture of these neurotransmitters by the dendritic spines of the efferent neuron or by direct conduction through gap junctions. Within neurons, large amounts of mRNA, tRNA, ribosomal RNA (rRNA) and sRNA are transported from soma to distal growth cones or distal dendrites for local translation. In addition, Schwann cells can deliver ribosomes, and probably mRNA, to injured axons 59 . MVBs are detected in dendrites and presynaptic terminals, where they can fuse with the plasma membrane to release exosomes into the synaptic cleft under the control of glutamatergic synaptic activity 60 . Exosomes mediate transsynaptic protein transfer at Drosophila melanogaster neuromuscular junctions 61 , raising the intriguing possibility that neurons might also exchange information in the form of RNA 62 . Pathogens hijack biological synapses to spread efficiently from cell to cell, reflecting the relevance of synapses as an entry port for exogenous genetic material. Some viruses use existing synapses to promote viral spreading, and viruses can also promote the establishment of new contacts (viral synapses) between infected and uninfected cells 63, 64 . The exosomal machinery is also exploited by pathogens. For example, HIV particles hijack dendritic cell exosomes to release virus and infect T cells 65 , and B cells infected with Epstein-Barr virus transfer exosomes containing viral miRNA to target cells, where the miRNA acts 23 (FIG. 3) .
Conclusions and perspectives
Accumulating evidence suggests that genetic material, mainly in the form of regulatory RNAs, can be exchanged between cells as extracellular information. Movement of viral-induced siRNAs and transgenes in plants has been known since 1997. However, the movement of endo genous sRNAs and its functional implications have only recently been demonstrated [3] [4] [5] . In C. elegans, transfer of exogenous and transgenic RNA is well supported, but evidence for functional transfer of endogenous RNA is still lacking. In D. melanogaster, uninfected cells can take up viral dsRNA, a mechanism of virusspecific intracellular immunity that prevents subsequent infection and virus spread 66 . The evidence discussed here indicates that movement and intercellular transfe r of regulatory RNA also occurs between mammalian cells.
Transfer of genetic material adds an exciting and novel dimension to the cellto-cell communication modes in complex organisms. However, important questions remain. Defining the routes through which cell-to-cell genetic transfer occurs is a major area of research. Extracellular vesicles were among the first vehicles confirmed to transfer genetic material, and some of the mechanisms through which extracellular vesicles are shuttled from cell to cell have been elucidated. However, the biological significance of this transfer remains unclear. In vitro approaches based on overexpression of mRNA or miRNA have shown that these molecules are functional in their new location. This phenomenon is extremely interesting from the point of view of gene therapy. The outstanding challenges now are to define whether transfer occurs at endogenous levels of these molecules and to elucidate the physiological importance of this movement.
Substantial progress has been made in plants regarding the nature of the information that is transferred. RNA duplexes of 21 or 24 nucleotides have been shown to move from cell to cell through plasmodesmata, and silencing signals may also be transported as single-stranded RNA (ssRNA) through the phloem. In C. elegans, SID-1 and SID-2 are thought to mediate the cellular uptake of dsRNA. The nature of the sRNAs that can be transferred in mammals still needs to be defined.
A phenomenon apparently exclusive to plants and C. elegans is that the silencing signal can be amplified, thereby inducing systemic silencing. Amplification of the Box 2 | The therapeutic and diagnostic potential of RNA-based communication Circulating cell-free nucleic acids have promising potential as non-invasive diagnostic markers for pathological processes such as chronic inflammation, cancer and cardiovascular disease 70, 71 . Detection of genetic biomarkers in the blood of patients with cancer might provide insight into the genetic status of individual tumours and the tissue origin of cancers of unclear primary origin 72 . Another exciting area is the existence of cell-free fetal DNA and mRNA in the blood of pregnant women, as this opens the possibility of extending the current armoury of non-invasive methods for prenatal diagnosis 73 . Delivery of nucleic acids to target cells is a major challenge for clinical medicine, offering a possible therapeutic strategy for regenerative medicine and the treatment of cancer and viral infection. The main obstacle to achieving gene silencing by RNA interference (RNAi) technologies in vivo is the delivery to specific cells and tissue. Several strategies have been suggested for systemic delivery of small interfering RNA (siRNA). One strategy involves chemically modified siRNAs, synthetic nanoparticles or exosomes 74 . An advantage of exosomes as RNA delivery vehicles is that they do not activate the interferon response and are, in principle, safer and more manageable than cell therapy. Unlike soluble factors, exosomes are protected from the environment by their lipid bilayer and can reach their target cells. A second advantage is that extracellular vesicles can deliver multiple messages simultaneously, including specific subsets of mRNA, microRNA (miRNA) or proteins. This factor highlights the need to expand our knowledge of how specific genetic messages are selected for incorporation into exosomes, and how vesicles that contain mRNA and miRNA are released and circulate in the bloodstream.
RNAi signal involves RNA-dependent RNA polymerases (RDRs), which copy secondary siRNAs corresponding to flanking sequences upstream or downstream of the originally targeted sequence. The secondary siRNAs are thus able to target parts of the mRNA not targeted by the original siRNA 67, 68 . The first functional mammalian homologue of RDRs was recently identified in human cells 69 . Future challenges include determining whether amplification of RNAi signals occurs in mammals and whether RDR-related molecules are involved.
The exchange of genetic material occurs mainly in two ways and, depending on the pathway used, genetic communication can occur over a distance or be confined to the local microenvironment. In one mode of transfer, particles secreted by the donor cell are taken up by an acceptor cell. These particles include extracellular vesicles such as exosomes and apoptotic bodies or ribonucleoproteins. The other mode of transfer involves the formation of intimate membrane contacts between donor and acceptor cells, such as gap junctions in animal cells and plasmodesmata in plants. Specialized contacts such as cellular synapses combine all these modes of genetic transfer. Cellular synapses and other cellular connective structures can provide specialized platforms for the intercellular transfer of genetic material. These structures could potentially be manipulated to achieve specific and efficient delivery of regulatory RNAs to either potentiate or suppress processes in the acceptor cell. The design of therapeutic delivery systems to take advantage of connective intercellular structures such as synapses holds the promise of specific delivery of 'therapeutic' exosomes to selected target cells. The therapeutic and diagnostic potential of RNA-based communicatio n is just emerging
